CatalYm begins phase 2b trial of visugromab in second-line liver cancer treatment

7th April 2026 Uncategorised 0

Study expands development of the antibody into hepatocellular carcinoma

More: CatalYm begins phase 2b trial of visugromab in second-line liver cancer treatment
Source: News